Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04011215 · ClinicalTrials.gov registry record · NA
Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)
A NA study, sponsored by Murdoch Childrens Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT04011215: Completed NA study, sponsored by Murdoch Childrens Research Institute.
NCT04011215 is a NA study that has completed, run by Murdoch Childrens Research Institute. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04011215, a NA study, has completed, sponsored by Murdoch Childrens Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The study is a sequentially recruited, cross-over-cohort, outpatient-based evaluation of the effectiveness of wool clothing, as compared to standard clothing, in reducing the severity of childhood atopic dermatitis (eczema) over two consecutive six-week periods.
Primary Outcome
blinded assessor administered EASI (units on a scale), will assess change from baseline. A score is obtained ranging from 0-72 based on erythema, papulation, excoriation and lichenification, each graded 0-3 for each of four body regions (head and neck, upper limbs, trunk, lower limbs) that are weighted according to surface area representation. A higher number indicates increased severity.
Interventions
- OTHER standard clothing
- OTHER wool clothing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2024-10-31 |
| Phase | NA |
What the finished NCT04011215 record still lists
NCT04011215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which standard clothing is the first listed.
NCT04011215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04011215 about?
NCT04011215 is a clinical study titled "Wool Clothing for the Management of Childhood Atopic Dermatitis (DESSINE2)". The study is a sequentially recruited, cross-over-cohort, outpatient-based evaluation of the effectiveness of wool clothing, as compared to standard clothing, in reducing the severity of childhood atopic dermatitis (eczema) over two consecutive six-week periods.
What is the current status of trial NCT04011215?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-09-23. Estimated completion is 2024-10-31.
What interventions are being tested in trial NCT04011215?
The interventions under investigation include: standard clothing (OTHER), wool clothing (OTHER).
Who is sponsoring clinical trial NCT04011215?
This trial is sponsored by Murdoch Childrens Research Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04011215's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI